Top Healthcare Stock Positions of a $65 Billion Fund

Following is information on Man Investment Group’s top holdings in the Healthcare sector:

  • Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ): On 3/31/11 Man Investments reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 6/30/11, Man Investmemts held 21,938 shares with a market value of $731,632. This comprised 0.56% of the total portfolio. The net change in shares for this position over the two quarters is 21,938. About the company: Jazz Pharmaceuticals, Inc. develops and markets treatments for neurological and psychiatric conditions. The Company produces treatments for cataplexy, excessive daytime sleepiness, and ethylene glycol and methanol poisoning in humans.
  • Amerigroup Corp. (NYSE:AGP): On 3/31/11 Man Investments reported holding 8,628 shares with a market value of $554,349. This comprised 0.38% of the total portfolio. On 6/30/11, Man Investmemts held 10,009 shares with a market value of $705,334. This comprised 0.54% of the total portfolio. The net change in shares for this position over the two quarters is 1,381. About the company: AMERIGROUP Corporation, a multi-state managed healthcare company, serves people who receive healthcare benefits through state-sponsored programs. Programs include Medicaid, Children’s Health Insurance Program, and Family Care. The Company provides managed care and medical management programs, as well as offers community-based education and outreach programs.
  • Mylan, Inc. (NASDAQ:MYL): On 3/31/11 Man Investments reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 6/30/11, Man Investmemts held 28,569 shares with a market value of $704,797. This comprised 0.54% of the total portfolio. The net change in shares for this position over the two quarters is 28,569. About the company: Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.
  • Healthspring, Inc. (NYSE:HS): On 3/31/11 Man Investments reported holding 14,932 shares with a market value of $558,009. This comprised 0.38% of the total portfolio. On 6/30/11, Man Investmemts held 15,263 shares with a market value of $703,777. This comprised 0.54% of the total portfolio. The net change in shares for this position over the two quarters is 0,331. About the company: Healthspring, Inc. is a health maintenance organization. The Company serves Medicare recipients with a comprehensive network of hospitals and physicians.
  • Biogen Idec, Inc. (NASDAQ:BIIB): On 3/31/11 Man Investments reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 6/30/11, Man Investmemts held 6,535 shares with a market value of $698,722. This comprised 0.54% of the total portfolio. The net change in shares for this position over the two quarters is 6,535. About the company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.
  • Viropharma, Inc. (NASDAQ:VPHM): On 3/31/11 Man Investments reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 6/30/11, Man Investmemts held 37,403 shares with a market value of $691,956. This comprised 0.53% of the total portfolio. The net change in shares for this position over the two quarters is 37,403. About the company: ViroPharma Incorporated is a biopharmaceutical company committed to the commercialization, development, and discovery of new medicines. The Company’s products include a treatment for prophylaxis of hereditary angioedema as well a capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection and enterocolitis.
  • Watson Pharmaceuticals, Inc. (NYSE:WPI): On 3/31/11 Man Investments reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 6/30/11, Man Investmemts held 9,882 shares with a market value of $679,190. This comprised 0.52% of the total portfolio. The net change in shares for this position over the two quarters is 9,882. About the company: Watson Pharmaceuticals, Inc. develops, manufactures, and sells generic and brand name pharmaceutical products. The Company’s core focus is specialty products, nephrology, urology, and generic products.
  • Medicis Pharmaceutical Corp. (NYSE:MRX): On 3/31/11 Man Investments reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 6/30/11, Man Investmemts held 17,774 shares with a market value of $678,434. This comprised 0.52% of the total portfolio. The net change in shares for this position over the two quarters is 17,774. About the company: Medicis Pharmaceutical Corporation provides pharmaceuticals focusing on the treatment of dermatological, pediatric, and podiatric conditions, as well as aesthetics medicine. The Company has branded prescription products in therapeutic categories such as acne, asthma, eczema, fungal infections, hyperpigmentation, photoaging, psoriasis, and rosacea.
  • Impax Laboratories, Inc. (NASDAQ:IPXL): On 3/31/11 Man Investments reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 6/30/11, Man Investmemts held 31,097 shares with a market value of $677,604. This comprised 0.52% of the total portfolio. The net change in shares for this position over the two quarters is 31,097. About the company: Impax Laboratories, Inc. develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. The Company specializes in the development of niche and controlled release generics, as well as the development of branded products.
  • Covance, Inc. (NYSE:CVD): On 3/31/11 Man Investments reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 6/30/11, Man Investmemts held 11,380 shares with a market value of $675,631. This comprised 0.52% of the total portfolio. The net change in shares for this position over the two quarters is 11,380. About the company: Covance Inc. is a contract research organization providing a wide range of integrated product development services on a worldwide basis. The Company’s customers include the pharmaceutical, biotechnology, and medical device industries. Covance also provides health economics and outcomes services, as well as laboratory testing services.

(Note: Data about Man Investment Group’s stock holdings are sourced from whalewisdom.com.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>